From 2012 to 2022, the hormonal and spermicide-based contraceptives market in Chile witnessed fluctuating trends. The market size peaked in 2012 at $144.15 million and experienced a general downward trajectory through 2017, with minor relief from a 20.05% year-on-year increase in 2018. From 2018, the market faced volatility, with alternating years of growth and decline, most notably a 7.18% drop in 2019 and a 5.35% decrease in 2022. The average annual growth rate (CAGR) over the last five years was 1.89%, indicating modest market growth during this period.
Future trends to watch for in the contraceptives market in Chile include potential shifts in consumer preferences towards non-hormonal alternatives, regulatory changes impacting product availability, and technological advancements in contraceptive methods. Sustainability and environmental concerns may also drive innovation in this sector.
How does Chile rank in Contraceptives (Based on Hormones or Spermicides) Market Size Value?
| # | 17 Countries | US Dollars | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Germany | 483,630,000 | 2023 | -0.78% | -0.58% | View data |
| 2 | 2 Argentina | 368,560,000 | 2023 | +2.14% | +3.2% | View data |
| 3 | 3 Italy | 242,670,000 | 2023 | -8.82% | -9.17% | View data |
| 4 | 4 Spain | 214,090,000 | 2023 | -11.7% | -7.16% | View data |
| 5 | 5 Chile | 123,060,000 | 2023 | -0.61% | -1.89% | |
| 6 | 6 Thailand | 74,049,000 | 2023 | -0.41% | +0.22% | View data |
| 7 | 7 Poland | 65,882,000 | 2023 | -6.03% | -4.93% | View data |